Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cardiovascular therapy problems in the elderly patient].

P Carbonin1, R Bernabei, L Carosella

  • 1Cattedra di Gerontologia e Geriatria, Università Cattolica del Sacro Cuore, Roma.

Cardiologia (Rome, Italy)
|December 1, 1991
PubMed
Summary

Managing cardiovascular drugs in elderly patients over 75 requires careful consideration due to increased risks. Evidence-based therapies and individualized dosing are crucial for safe and effective treatment in this population.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age of onset of mental disorders and use of mental health services: needs, opportunities and obstacles - CORRIGENDUM.

Epidemiology and psychiatric sciences·2022
Same author

Reply Letter - Polypharmacy is a determinant of hospitalization in Parkinson's disease.

European review for medical and pharmacological sciences·2021
Same author

Prehabilitation and heart failure: perspective in primary outcomes, a randomized controlled trial.

European review for medical and pharmacological sciences·2021
Same author

International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines.

The journal of nutrition, health & aging·2021
Same author

Polypharmacy is a determinant of hospitalization in Parkinson's disease.

European review for medical and pharmacological sciences·2021
Same author

The New Challenge of Geriatrics: Saving Frail Older People from the SARS-COV-2 Pandemic Infection.

The journal of nutrition, health & aging·2020

Area of Science:

  • Geriatric Medicine
  • Cardiovascular Pharmacology

Context:

  • Elderly patients (over 75) face higher risks of comorbidity and dependence.
  • Current clinical trials often exclude this demographic, limiting data on drug efficacy and safety.
  • Therapeutic management must prioritize quality of life over single pathology resolution.

Purpose:

  • To highlight the critical need for careful therapeutic management in elderly patients over 75.
  • To address the lack of specific data on cardiovascular drug efficacy and safety in this age group.
  • To provide guidelines for optimizing drug therapy in older adults.

Summary:

  • Therapeutic management for patients over 75 demands extreme caution due to increased comorbidity and dependence.
  • Multidimensional evaluation, including psychological and social factors, is essential.

Related Experiment Videos

  • Drug selection should prioritize proven efficacy, with careful dosing based on renal function and body weight, and strict clinical monitoring for adverse reactions.

    • Impact:

    • Informs clinical practice for geriatric cardiovascular care.
    • Emphasizes the importance of individualized treatment plans for elderly patients.
    • Contributes to safer and more effective medication use in advanced age.